Open access
Velaglucerase alfa in the treatment of Gaucher disease type 1
Clinical Investigation · 2011
DOI: 10.4155/cli.10.21 ↗At a glance
Journal article in Clinical Investigation, 2011. Written by Thomas A Burrow and 1 co-authors. Institution: Cincinnati Children's Hospital Medical Center, Division of Human Genetics, 3333 Burnet Avenue, MLC 4006, Cincinnati, OH 45229-43039, USA. Cited 30 times so far (Crossref); 22 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS.
Abstract (original language)
Abstract non disponibile.
Authors and institutions
- Cincinnati Children's Hospital Medical Center, Division of Human Genetics, 3333 Burnet Avenue, MLC 4006, Cincinnati, OH 45229-43039, USA.
Funding
- NIDDK NIH HHS
Cite
APA
Burrow, T. A., & Grabowski, G. A. (2011). Velaglucerase alfa in the treatment of Gaucher disease type 1. Clinical Investigation. https://doi.org/10.4155/cli.10.21
Vancouver
Burrow TA, Grabowski GA. Velaglucerase alfa in the treatment of Gaucher disease type 1. Clinical Investigation. 2011. doi:10.4155/cli.10.21
BibTeX
@article{Burrow2011,
author = {Burrow, Thomas A and Grabowski, Gregory A},
title = {Velaglucerase alfa in the treatment of Gaucher disease type 1},
journal = {Clinical Investigation},
year = {2011},
doi = {10.4155/cli.10.21}
}
EUVIMED